Marketing-authorisation holder · United States

Carnegie

United States8 medicines1 country

8 medicines in 1 country, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

8 medicines

Medicine	Substance	Country	Status	Authorised
CLINDAMYCIN PHOSPHATE1% base · Swab	Clindamycin	United States	Marketed	2000
E.E.S.200mg base/5ml · Granule	Erythromycin	United States	Marketed	1965
E.E.S. 400400mg base · Tablet	Erythromycin	United States	Marketed	1982
ERY-TAB250mg \| 333mg \| 500mg · Tablet, delayed release	Erythromycin	United States	Marketed	1982
ERYPED200mg base/5ml \| 400mg base/5ml · Granule	Erythromycin	United States	Marketed	1965
ERYTHROMYCIN250mg · Capsule, delayed rel pellets	Erythromycin	United States	Marketed	1986
LATANOPROST0.005% · Solution/drops	Latanoprost	United States	Marketed	2011
LOMUSTINE100mg \| 10mg \| 40mg · Capsule	Lomustine	United States	Marketed	2025

Where it holds or makes medicines, with how many are current.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Marketing-authorisation holder · United States

United States8 medicines1 country

8 medicines in 1 country, as authorisation holder.

Every medicine in the registers under its name, current ones first.

8 medicines

Medicine	Substance	Country	Status	Authorised
CLINDAMYCIN PHOSPHATE1% base · Swab	Clindamycin	United States	Marketed	2000
E.E.S.200mg base/5ml · Granule	Erythromycin	United States	Marketed	1965
E.E.S. 400400mg base · Tablet	Erythromycin	United States	Marketed	1982
ERY-TAB250mg \| 333mg \| 500mg · Tablet, delayed release	Erythromycin	United States	Marketed	1982
ERYPED200mg base/5ml \| 400mg base/5ml · Granule	Erythromycin	United States	Marketed	1965
ERYTHROMYCIN250mg · Capsule, delayed rel pellets	Erythromycin	United States	Marketed	1986
LATANOPROST0.005% · Solution/drops	Latanoprost	United States	Marketed	2011
LOMUSTINE100mg \| 10mg \| 40mg · Capsule	Lomustine	United States	Marketed	2025

Where it holds or makes medicines, with how many are current.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

United States	8	8	0	Companies All medicines

The active substances in most of its medicines.

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Report an error or request removalCorrections from the company itself are welcome.

Ranked by their number of medicines.